Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: A pilot study

Surgical Infections

Volumn 8, Issue 1, 2007, Pages 73-81

  Hallal, Ali ^a   Cohn, Stephen M ^b,d   Namias, Nicholas ^a   Habib, Fahim ^a   Baracco, Gio ^a   Manning, Ronald J ^a   Crookes, Bruce ^c   Schulman, Carl I ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CREATININE; PLACEBO; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ADULT; AGED; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; PILOT STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADMINISTRATION, INHALATION; ADULT; AGED; ANTI-BACTERIAL AGENTS; APACHE; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PILOT PROJECTS; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 34247129544     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.051     Document Type: Conference Paper

References (27)

1. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients: Microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343-349.
2. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilation-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440.
3. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866-869.
4. Timsit JF, Chevret S, Valcke J, et al. Mortality of nosocomial pneumonia in ventilated patients: Influence of diagnostic tools. Am J Respir Crit Care Med 1996;154; 116-123.
5. Chastre J, Fagon JY. Ventilator associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
6. Sieger B, Berman SJ, Geckler RW, Farkas SA. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: A randomized study. Meropenem Lower Respiratory Infection Group. Crit Care Med 1997;25: 2067-2074.
7. Cometta A, Baumgartner JD, Lew D, et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 1994;38:1309-1313.
8. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. β Lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials. BMJ 2004;328: 668-673.
9. Montravers P, Veber B, Auboyer C, et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: Results of the Eole study. Crit Care Med 2002;30:368-375.
10. Croce MA, Fabian TC, Stewart RM, et al. Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma 1993; 35:303-311.
11. Carcas AJ, Garcia-Statue JL, Zapater P, Frias-Iniesta J. Tobramycin penetration into epithelial lining fluid of patients with pneumonia. Clin Pharmacol Ther 1999; 65:245-250.
12. Wood GC, Boucher BA. Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 2000; 20:166-181.
13. Goldstein I, Wallet F, Nicolas-Robin A, et al. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002;166:1375-1381.
14. Makhoul IR, Merzbach D, Lichtig C, Berant M. Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: Comparison of aerosol and systemic administration. J Infect Dis 1993; 168:1296-1299.
15. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.
16. Kahler DA, Schowengerdt KO, Fricker FJ, et al. Toxic serum trough concentrations after administration of nebulized tobramycin. Pharmacotherapy 2003;23: 543-545.
17. Wood GC, Boucher BA, Croce MA, et al. Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy 2002;22:972-982.
18. Le Conte P, Potel G, Clementi E, et al. [Administration of tobramycin aerosols in patients with nosocomial pneumonia: A preliminary study] (Fre). Presse Med 2000;29:76-78.
19. Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia. Chest 1992;102(Suppl):553S- 556S.
20. Luna CM, Blanzaco D, Niedman MS, et al. Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical infection score as an early clinical predictor of outcome. Crit Care Med 2003;31: 676-682.
21. Gilbert DN. Aminoglycosides. In: Mendel, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5th edition. Philadelphia: Churchill Livingstone, 2000:307-325.
22. Gilbert DN, Lee BL, Dworking RJ, et al. A randomized comparison of the safety and efficacy of one-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med 1998; 105:182-191.
23. Gilbet DN, Bennett WM. Use of antimicrobial agents in renal failure. Infect Dis Clin North Am 1989;3: 517-531.
24. O'Doherty MJ, Thomas SHL. Nebulizer therapy in the intensive care unit. Thorax 1997;52(Suppl 2):S56-S59.
25. Feeley TW, DuMoulin GC, Hedley Whyte J, et al. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975;293:471-475.
26. Stoutenbeek CP, van Saene HFK, Miranda DR, et al. Nosocomial gram-negative pneumonia in critically ill patients: A 3-year experience with a novel therapeutic regimen. Intensive Care Med 1986;12: 419-423.
27. Le Conte P, Potel G, Peltier P, et al. Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis 1993;147:1279-1282.